PRESS RELEASE >> JULY 14 - 2005    


Collaborative Agreement Reached with Premier Research Institution

 

VANCOUVER, British Columbia, July 14, 2005 (PRIMEZONE) -- ProtoKinetix, Inc. (OTCBB:PKTX) announces a major collaborative agreement with one of the world's most prestigious blood specialty institutions. The Etablissment Francais du Sang-Alsace (EFS), which is affiliated with the Louis Pasteur University in Strasbourg, provides the premier research facilities in the field of hematology. EFS will be deploying their considerable physical and intellectual resources to the testing of synthesized AFGP characteristics as they apply to the preservation of blood products. With extensive world wide operations in Europe, Asia, Africa, and South America, EFS is in a unique position to identify the vital role that synthetic AFGP can play in the storage and transportation of blood products throughout the world.

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP™ products.

For more detailed information, please visit our website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Ross L. Senior, President and CEO

ProtoKinetix Inc.
Investor Contact
Blair Henderson, 604-687-9887

 


 
 
 

 

HOME - AFGP to AAGP - AAGP TESTS - COMMERCIAL APPLICATIONS - PRESS RELEASES - CONTACT

Copyright 2008 © Protokinetix Inc. All rights reserved. | Privacy Policy | Safe Harbor |